Story of IVI’s oral cholera vaccines

Cholera is an acute diarrheal infection caused by ingestion of food or water contaminated with the bacterium Vibrio cholerae. It affects both children and adults and can kill within hours if not properly treated.  According to the WHO, there are 1.4 to 4.3 million cases […]

The GTFCC Marks a Year of Progress Toward Ending Cholera Worldwide


‘Present and Future of Vaccine Development’ Seminar series: Genetic Engineering of Vibrio cholerae strains to fight against cholera

  August 23, SEOUL, South Korea. In our seminar series ‘Present and Future of Vaccine Development’, we were happy to welcome our latest speaker: Dr. Dong Wook Kim from the Department of Pharmacy at Hanyang University. Based upon their insight into the genetic alterations in […]

IVI Awarded $4.5 Million Grant to Increase Accessibility of Oral Cholera Vaccine

October 28, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI) has received a $4.5 million grant from the Bill & Melinda Gates Foundation to simplify the current oral cholera vaccine (OCV) and further increase its accessibility. To date, the Gates Foundation has […]